This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Newell Co.: Acquisition Strategy (Spanish Version)
Collis, David J.; Johnson, ElizabethCase HBS-718S17StrategyNewell es un fabricante de $ 1,5 mil millones y distribuidora de productos caseros y hardware de baja tecnología, orientados a servir a los compradores de volumen. En 1992, Newell está considerando dos enfoques para ampliar su línea de productos actual con las adquisiciones de Sanford Corporation, un fabricante de $ 140 millones y comercializadora de artículos de escritura y artículos de oficina, y Levolor, un fabricante de $ 180 millones de los ...Starting at €8.20
-
Portfolio Planning at CIBA-GEIGY and the Newport Investment Proposal (Spanish version)
Collis, David J.; Johnson, ElizabethCase HBS-719S09StrategyCovers the history of portfolio planning at CIBA-GEIGY, a leading Swiss chemical and pharmaceutical company, beginning with the introduction of the process in the mid-1980s. The discussion extends to the application of portfolio planning techniques to a specific investment proposal: the comprehensive modernization of a plant dedicated to the production of high-quality specialty pigments.Starting at €8.20
-
Cooper Industries: estrategia corporativa (B)
Collis, David J.; Johnson, ElizabethCase HBS-706S12StrategyLleva a los estudiantes al día con respecto a una decisión reciente del presidente.Starting at €5.74
-
Capturing Confectionery (D) (Spanish version)
Collis, David J.; Stuart, Toby; Smith, TroyCase HBS-708S48StrategyIn late 2002, global confectionery and beverage maker Cadbury Schweppes needed to decide whether or not to make an acquisition bid for Adams, an underperforming gum company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing especially on chocolate and gum; and details the a...Starting at €5.74
-
To Acquire or Not to Acquire? An Update (Spanish version)
Alcacer, Juan; Collis, David J.; Furey, MaryCase HBS-712S07StrategyTo Acquire or Not to Acquire?" details the Walt Disney Company's acquisition of Pixar, including deal terms, executive appointments, and operating guidelines for the two studios.Starting at €8.20
-
The Family Business: An Introduction
Tàpies, JosepTechnical Note DGN-651-EStrategyThis technical note presents the impact that family businesses can have on different aspects of a country's economy. It discusses the main reasons contributing to their lack of development and continuity and analyzes their particular strengths. It also covers the characteristics associated with the groups of people who may have an interest in the family business and how they relate to one another, along with the different types of family business...Starting at €8.20
-
Life Cycles in the Family Business
Tàpies, Josep; Gallo, Miguel ÁngelTechnical Note DGN-652-EStrategyDepending on a family business's stage of development, the types of conflicts that may arise, as well as the best ways of dealing with them, can vary greatly. Proper resolution of the issues associated with each stage should be undertaken far enough in advance. Many common problems can be anticipated and there are well-known methods for managing them. This technical note provides an analysis of the following four typical situations: 1) The tripl...Starting at €8.20
-
Succession at Merck KGaA - Teaching Note
Neumann, Frederic A.; Tàpies, JosepTeaching Note DGT-52-ECorporate Governance, Leadership and People Management, StrategyThe case focuses on the issue of succession in terms of family, management and governing bodies. It describes in some detail the period between 1963 and 2000, when Hans Joachim Langmann, the charismatic leader, was at the helm of Merck. It illustrates the consequent internationalization, the research focus on liquid crystals for LC displays instead of pharmaceuticals and the patriarchal leadership style of this time. Next, the five-year stint of ...Starting at €0.00
-
Novartis: A Transformative Deal
Collis, David J.; Hartman, AshleyCase HBS-717453-EStrategyWhen Joe Jimenez became CEO of Swiss-based Novartis in 2010 replacing longtime CEO Dan Vasella, he assumed control of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into sixteen distinct business units ranging from animal health to oncology while "actively fostering competition between those divisions for resources." Shortly after assumi...Starting at €8.20
-
SoulCycle
Collis, David J.; Van Den Steen, Eric; Hartman, AshleyCase HBS-717454-EStrategyCo-founders Julie Rice and Elizabeth Cutler have grown SoulCycle from a business idea in 2006 to a major presence among urban boutique fitness studios in 2015. In March 2015, fitness company Equinox approaches them with an offer to buy them out. Evaluating the offer requires an assessment of market or industry attractiveness and of SoulCycle's (potential) competitive advantage.Starting at €8.20